Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Yale University
Asociación Civil Impacta Salud y Educación, Peru
Information provided by (Responsible Party):
Duerr, Ann C, Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier:
NCT01377168
First received: June 17, 2011
Last updated: August 8, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2017
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)